LINTEX
920106
LINGOOD
833284
NTGEC
870436
CG MED EQUIP.
838810
Jiayu Holding
300117
CN Stock MarketDetailed Quotes
000710 Berry Genomics
- 12.88
- -0.77-5.64%
Market Closed Feb 28 15:00 CST
4.55BMarket Cap-16.16P/E (TTM)
14.07High12.80Low411.49KlotVolume13.27Open13.65Pre Close554.35MTurnover12.93%Turnover RatioLossP/E (Static)353.52MShares14.9752wk High2.43P/B4.10BFloat Cap6.6652wk Low15.02Limit Up318.26MShs Float98.00Historical High12.29Limit Down9.30%Amplitude1.60Historical Low--Dividend TTM13.47Avg Price210.39KlotAsk--Div YieldTTM100Lot Size173.25KlotBid
Berry Genomics News
Berry Genes: 000710 Berry Gene Investor Relations Management Information 20250224
Berry Genes: 000710 Berry Gene Investor Relations Management Information 20250211
Berry Genomics: Announcement on Abnormal Fluctuations in Stock Trading
Berry Gene: Announcement on the Withdrawal of the Judicial Auction of Part of the Company\'s Shares Held by the Controlling Shareholder
Berry Genomics: 2024 Annual Results Forecast
Berry Gene: Announcement on Joint Investments with Professional Investment Institutions
Berry Gene: An indicative announcement that part of the company\'s shares held by the controlling shareholder will be judicially auctioned
Berry Gene: Announcement on the judicial re-freezing of the controlling shareholder\'s shares
Berry Gene: Announcement on the Expiration of the Implementation Period and Implementation Results of the Controlling Shareholder\'s Passive Shareholder Reduction
Berry Gene: Announcement on the suspension of the judicial auction of part of the company\'s shares held by the controlling shareholders\' concerted actions
Berry Genomics: Q3 2024 Report
Berry Gene: Announcement of Supervisory Board Resolutions
Berry Genomics: Board Resolution Announcement
Berry Genes: Announcement on the Wholly-owned Subsidiary Chromosome Copy Number Variation Data Analysis Software Obtaining a Medical Device Registration Certificate
Berry Gene: An indicative announcement that part of the company\'s shares held by those acting in agreement with the controlling shareholders will be judicially auctioned
Berry Genomics: Summary of Half-Year Report in 2024.
Berry Genomics: Announcement of the resolution of the Supervisory Board on the semi-annual report.
Berry Genomics: Financial Report for the first half of 2024.
Berry Genomics: Announcement of Board of Directors' resolution for semi-annual report.
Berry Genomics: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
